Return to homepagePandemic Pact

MoKoCo19 - Modellbasierte Datenanalyse für die bevölkerungsbezogene prospektive COVID-19-Kohortenstudie in München

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:7 publications

Grant number: 01KI20271

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $50,612.83
  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)
  • Principal Investigator

    Prof. Jan Peter Hasenauer
  • Research Location

    Germany
  • Lead Research Institution

    Rheinische Friedrich-Wilhelms-Universität Bonn
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Impact/ effectiveness of control measures

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

epidemiological study - Das Projekt MoKoCo19 hat das Ziel die Wirkung nicht-pharmakologischer Interventionen wie z. B. Schulschließungen und Kontaktbeschränkungen genauer zu quantifizieren und damit die Vorhersage des Pandemieverlaufs zu verbessern. Kern des Vorhaben sind modellbasierte Analysen der bevölkerungsbezogenen prospektiven Münchner COVID-19-Kohortenstudie in Kombination mit den vom Robert Koch-Institut gesammelten Daten. Die Resultate sollen dazu dienen politische Entscheidungsträger zu unterstützen den besten Weg aus der aktuellen Krise zu finden. epidemiological study - The MoKoCo19 project aims to evaluate the effects of non-pharmacological interventions such as school closures and contact restrictions and thus to improve the prediction of the to improve the course of the pandemic. At the core of the project are model-based analyses of the population-based prospective Munich COVID-19 cohort study in combination with the COVID-19 cohort study conducted by Robert Koch Institute collected data. The results should serve political decision makers to help find the best way out of the current crisis." Translated with www.DeepL.com/Translator (free version)

7 Publications linked via Europe PMC

Waning of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in 2020: A 12-month-evaluation in three population-based European studies.

Differential DNA methylation 7 months after SARS-CoV-2 infection.

Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison.

Integrative modelling of reported case numbers and seroprevalence reveals time-dependent test efficiency and infectious contacts.

Identifiability analysis for models of the translation kinetics after mRNA transfection.

Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.

A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay.